Although STAT3 inhibition alone retains some pro-apoptotic activity, as previously shown in studies involving STAT3-dependent leukemias [76,92,93], its contribution to the synergistic effect is clearly potentiated by a functional p53 axis. This evidence concerns the gene TP53 and leukemia.